Rep. Kevin Hern Sells Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Rep. Kevin Hern sold $15,001–$50,000 of UnitedHealth Group stock on September 10 through the Hern Family Foundation account. He also reported selling stakes in several other companies, including CenterPoint Energy, STERIS, NextEra Energy and Home Depot.
• UnitedHealth reported quarterly earnings of $6.38 per share, exceeding the $4.94 analyst consensus, while revenue rose 0.4% year over year to $112.03 billion. The company maintained 2026 earnings guidance of $19.50–$20.00 per share.
• Analysts hold a consensus “Moderate Buy” rating on UNH, with an average price target of $456.56 versus the reported opening price of $377.52. UnitedHealth also pays a quarterly dividend of $2.32, representing a 2.5% annualized yield.

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on September 10th. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account.

Representative Kevin Hern also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of CenterPoint Energy NYSE: CNP on 9/15/2026.
• Sold $1,001 - $15,000 in shares of TJX Companies NYSE: TJX on 9/15/2026.
• Sold $15,001 - $50,000 in shares of STERIS NYSE: STE on 9/15/2026.
• Sold $1,001 - $15,000 in shares of Seagate Technology NASDAQ: STX on 9/15/2026.
• Sold $15,001 - $50,000 in shares of NextEra Energy NYSE: NEE on 9/14/2026.
• Sold $1,001 - $15,000 in shares of Marsh & McLennan Companies NYSE: MRSH on 9/14/2026.
• Sold $15,001 - $50,000 in shares of IQVIA NYSE: IQV on 9/14/2026.
• Sold $15,001 - $50,000 in shares of Home Depot NYSE: HD on 9/14/2026.
• Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 9/14/2026.
• Sold $15,001 - $50,000 in shares of Emerson Electric NYSE: EMR on 9/14/2026.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $377.52 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a market capitalization of $338.86 billion, a PE ratio of 24.29, a price-to-earnings-growth ratio of 1.42 and a beta of 0.61. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a fifty day simple moving average of $397.90 and a 200-day simple moving average of $375.22.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same quarter in the previous year, the business posted $4.08 EPS. The firm's revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 19.85 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a $2.32 dividend. The ex-dividend date was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio is 59.72%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Wall Street Zen upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Sanford C. Bernstein reaffirmed an "outperform" rating on shares of UnitedHealth Group in a report on Wednesday, September 2nd. Cantor Fitzgerald restated an "overweight" rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Royal Bank Of Canada increased their price target on UnitedHealth Group from $463.00 to $478.00 and gave the stock an "outperform" rating in a research report on Friday, July 17th. Finally, BMO Capital Markets set a $512.00 target price on UnitedHealth Group in a research report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $456.56.

Institutional Trading of UnitedHealth Group

A number of hedge funds and other institutional investors have recently made changes to their positions in UNH. Atomic Invest LLC boosted its holdings in UnitedHealth Group by 62.3% during the second quarter. Atomic Invest LLC now owns 99 shares of the healthcare conglomerate's stock worth $41,000 after buying an additional 38 shares in the last quarter. QRG Capital Management Inc. boosted its position in shares of UnitedHealth Group by 18.2% in the second quarter. QRG Capital Management Inc. now owns 135,858 shares of the healthcare conglomerate's stock worth $56,467,000 after buying an additional 20,916 shares during the period. Envestnet Portfolio Solutions Inc. lifted its stake in UnitedHealth Group by 26.1% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 27,843 shares of the healthcare conglomerate's stock worth $11,572,000 after acquiring an additional 5,756 shares in the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of UnitedHealth Group by 20.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 1,951,573 shares of the healthcare conglomerate's stock valued at $811,130,000 after purchasing an additional 328,385 shares during the period. Finally, Andra AP fonden increased its stake in UnitedHealth Group by 10.1% in the 2nd quarter. Andra AP fonden now owns 111,175 shares of the healthcare conglomerate's stock valued at $46,208,000 after buying an additional 10,160 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.19% of the company's stock.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma's 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027. Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma's 1st Congressional District. He declared candidacy for the 2026 election. Kevin Hern went into business as a McDonald's franchisee in 1999. He acquired 10 McDonald's franchises by 2012. He served on the McDonald's National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.